Back
to sessions
Sep 28
Scientific
MODERATOR(S)
Ritchell van Dams, MD, MHS - Dana-Farber/Brigham and Women's Cancer Center
A. Bapsi Chakravarthy, MD, FASTRO - Vanderbilt University Medical Center
Credits
| AMA PRA Category 1 Credits: | 1.25 |
Presentations
-
10:45am - 10:55am ET
Short-Course Radiotherapy-Based Total Neoadjuvant Therapy with or without a PD-1 Inhibitor in pMMR Locally Advanced Rectal Cancer: Short-Term Results from a Randomized Phase 3 Trial (STELLAR II)
Speaker: Jing Jin, MD - State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science, Beijing -
10:55am - 11:05am ET
FAPI-Guided Radiotherapy + Cadonilimab with Systemic Therapy vs. Systemic Therapy Alone in Second-Line Treatment of Colorectal Peritoneal Metastasis (TORCH-PM01)
Speaker: Zhiyuan Zhang, MD - Fudan University Shanghai Cancer Center, Shanghai -
11:05am - 11:15am ET
-
11:15am - 11:25am ET
Immunotherapy Based Total Neoadjuvant Therapy with or without Short-Course Radiotherapy for Locally Advanced Rectal Cancer: Initial Results of TORCH-iTNT
Speaker: Yaqi Wang, MD - Fudan University Shanghai Cancer Center, Shanghai -
11:25am - 11:35am ET
A Novel Regimen of Liposomal Irinotecan Plus Capecitabine as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LipCap): A Phase II Trial
Speaker: Linlin Xiao, MS, RT - the fourth hospital of hebei medical university, Shijiazhuang -
11:35am - 11:45am ET
KRAS Variant-Specific Chemoradiation Response and Tumor Microenvironment Characterization in Locally Advanced Rectal Cancer: An Integrated Transcriptomic Profiling
Speaker: Jeril Lasington, MD - NYMC-Saint Clare's Health and Saint Mary's general hospital, Denville -
11:45am - 11:55am ETSpeaker: Krishan Jethwa, MD - Mayo, Rochester